American Capital Advisory’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57K Buy
225
+16
+8% +$248 ﹤0.01% 502
2026
Q1
$2.82K Buy
209
+58
+38% +$812 ﹤0.01% 478
2025
Q4
$1.88K Buy
151
+8
+6% +$86 ﹤0.01% 475
2025
Q3
$1.42K Buy
143
+10
+8% +$97 ﹤0.01% 485
2025
Q2
$1.19K Buy
133
+50
+60% +$423 ﹤0.01% 469
2025
Q1
$723 Hold
83
﹤0.01% 462
2024
Q4
$1.03K Hold
83
﹤0.01% 420
2024
Q3
$964 Hold
83
﹤0.01% 413
2024
Q2
$899 Buy
83
+12
+17% +$133 ﹤0.01% 380
2024
Q1
$684 Sell
71
-12
-14% -$145 ﹤0.01% 403
2023
Q4
$899 Buy
+83
New +$795 ﹤0.01% 380

Other funds holding VTRS

American Capital Advisory's VTRS Position: Q2 2026 in Review

American Capital Advisory increased its Viatris (VTRS) stake by 7.7% in Q2 2026, buying an estimated $248 and bringing the position to 225 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

American Capital Advisory first reported a position in VTRS in Q4 2023 and has held it in 11 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • American Capital Advisory held 225 shares of Viatris worth $3.57K as of Q2 2026.
  • American Capital Advisory bought 16 Viatris shares in Q2 2026, an estimated $248.
  • Viatris made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #502 holding.
  • American Capital Advisory first reported a position in Viatris in Q4 2023 and has held it in 11 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.